Episode 149: Myeloma Series, Pt. 9 - Maintenance for Multiple Myeloma (2026)
About this episode
This episode discusses maintenance strategies for managing multiple myeloma after initial therapy and transplant.
This week, we turn our attention to what we do in the maintenance setting for management of myeloma. At this point, our patient has gone through initial therapy; for patients who are able to undergo a transplant, we have consolidated their disease with a transplant; and now, we want to maintain that response using a lower dose of therapy, all while trying to minimize toxicity and maximize the patient’s quality of life. We discuss this in detail in this week’s episode! Content: - Why is lenolidomide (revlimid) our current standard of care? - What data do we have to add anti CD38 antibodies? - How is MRD being considered in this space? ** This episode is sponsored by Primum! To learn more, sign up for your free account, and to ask questions to Primum experts, visit primum.co/fellows ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube
Topics covered
- maintenance therapy
- multiple myeloma
- patient quality of life
- transplant management
- toxicity minimization
Keywords
- myeloma
- maintenance therapy
- lenolidomide
- revlimid
- anti CD38 antibodies
- MRD
- quality of life
Sponsors
Primum
Mentioned in this episode
Organizations: anti CD38 antibodies, Rouleaux University Medical Center
Products: lenolidomide, revlimid
More episodes of The Fellow on Call: The Heme/Onc Podcast
- Episode 157: Immune Thrombocytopenic Purpura Series, Pt 3- Challenging Scenarios in ITP
- Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory
- Episode 155: Immune Thrombocytopenic Purpura Series, Pt 1- First Line Management
- Episode 154: Ask The Program Directors-The Do’s and Don'ts of Applying to Hematology Fellowship (Career Development Series)
- Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing
- Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly
Explore listener stats, chart rankings, contacts and more on the The Fellow on Call: The Heme/Onc Podcast podcast page.